Table 1.

Responses to selected items on the prescription drug monitoring program (PDMP) online survey regarding opioid prescribing patterns

Do you prescribe long-acting or extended release opioids (e.g., transdermal fentanyl, oral methadone, oxycodone sustained release)? (175 respondents)
Yes, based on my clinical judgment	8.0 %
Yes, but only for verified refills (e.g., computer verification, appropriately timed empty container)	12.0 %
Yes, but if new prescription only in consultation with a patient's primary care or pain management provider	6.3 %
Yes, to treat severe pain more continuously	0.6 %
No	73.1 %
Under what circumstances would you support the requirement for mandatory review of a PDMP prior to writing a controlled substance prescription? (95 respondents; may answer more than once)
Prescriptions for more than 3 days of medication	12.6 %
Prescriptions for more than 5 days of medication	24.2 %
Prescribing of a schedule II medication	27.4 %
Prescribing to any patient unknown to the prescriber	23.2 %
Prescribing to patients screening positive for risk factors for misuse	54.7 %
Under no circumstances should it ever be mandatory	34.7 %
How often have you altered your prescribing to a patient after accessing the PDMP database? (90 respondents)
Given more of a controlled substance	68 %
Given less of a controlled substance	87 %
Occasionally changed practice (1–33 % of time accessed)	81 %
Often changed practice (67–100 %)	20 %